Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Leishmania
100%
Druggability
100%
Serine Protease
100%
Activity-based Protein Profiling
100%
Antileishmanial Drugs
40%
Serine Hydrolase
40%
Current Treatment
20%
High Cost
20%
Active Sites
20%
Leishmania Species
20%
Leishmaniasis
20%
New Drug Targets
20%
Parasitic Protozoa
20%
Drug Target
20%
Rhodamine B (Rh B)
20%
Quantitative Proteomics
20%
Serine Protease Inhibitor
20%
Expression Level
20%
Leishmania Mexicana
20%
Genetic Method
20%
Target Validation
20%
Leishmania Parasites
20%
Target Identification
20%
Lactacystin
20%
Prolyl Oligopeptidase
20%
Site-directed
20%
New Agents
20%
Carboxypeptidase
20%
Efficacy-toxicity
20%
Biotin
20%
Chymostatin
20%
Selective Inhibition
20%
Proteomic Mass Spectrometry
20%
New Mode of Action
20%
Profiling Methods
20%
Drug Discovery Program
20%
Targetable
20%
ITRAQ Labeling
20%
Fluorophosphonate Probe
20%
Pharmacology, Toxicology and Pharmaceutical Science
Leishmania
100%
Serine Proteinase
100%
Serine
28%
Hydrolase
28%
Diseases
28%
Leishmaniasis
14%
Drug Discovery
14%
Leishmania mexicana
14%
Target Identification
14%
Prolyl Endopeptidase
14%
Lactacystin
14%
Chymostatin
14%
Rhodamine
14%
Fluorophosphonic Acid Derivative
14%
Serine Proteinase Inhibitor
14%
Carboxypeptidase
14%
Biotin
14%
Protozoan
14%
Parasite
14%
Biochemistry, Genetics and Molecular Biology
Serine Protease
100%
Leishmania
100%
Serine Hydrolase
28%
Genetics
14%
Mass Spectrometry
14%
Active Site
14%
Serine Protease Inhibitor
14%
DNA Template
14%
Leishmania mexicana
14%
Quantitative Proteomics
14%
Life Cycle
14%
Drug Development
14%
Parasite
14%
Protozoan
14%
Expression Level
14%
Rhodamine
14%
Carboxypeptidase
14%
Biotin
14%
Prolyl Endopeptidase
14%
Immunology and Microbiology
Leishmania
100%
Serine
100%
Protozoa
14%
Mass Spectrometry
14%
Life Cycle
14%
Leishmaniasis
14%
Leishmania mexicana
14%
Oligopeptidase
14%
DNA Template
14%
Proteomics
14%
Parasite
14%
Therapeutic Target
14%
Proteinase
14%
Protease
14%
Biotin
14%